Recall Radar
All recallsMedicine & devices

Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Vial, For Intravenous Use Only, Rx Only, Manufactured by: Hainan Poly Pharm. Co.,…

Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial for weight-adjusted infusion.

Class III Medicine & devices FDA March 4, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Slate Run Pharmaceuticals — Columbus, OH
Severity
Class III — low
Reported
March 4, 2026
Quantity
N/A
Recall number
D-0343-2026
Status
Ongoing
Source
FDA

Where it went

Nationwide within the USA.

Other medicine & devices recalls

See every current recall on the live dashboard →